Ovarian Epithelial Carcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Epithelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy [Phase 2]
Phase 2 trial evaluating a standardized AHCC extract in ovarian cancer patients on adjuvant chemotherapy; the study is currently active but …
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma [EARLY_Phase 1]
A single-arm, open-label Phase 1 study evaluating SZ011 for ovarian epithelial carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab and bevacizumab with chemotherapy followed by pembrolizumab, bevacizumab, and olaparib in recurrent o…
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating the pharmacokinetics and safety of OvaRex MAb-B43.13 in ovarian epithelial carcinoma has been terminated.